How to continue Strattera after moving to Florida

If you’ve been struggling with ADHD symptoms—difficulty concentrating at work, forgetfulness, restlessness—you might be wondering whether you can access treatment without the hassle of scheduling multiple in-person doctor visits. The short answer: Yes, you can get ADHD non-stimulant medications like Strattera prescribed through telehealth in most cases. But the details matter, and understanding the current landscape of telehealth ADHD treatment can help you make informed decisions about your care.

Understanding ADHD Non-Stimulant Medications

Before diving into the telehealth rules, let’s clarify what we mean by ‘non-stimulant’ ADHD medications. While stimulant medications like Adderall and Ritalin are the most well-known ADHD treatments, non-stimulant options offer effective alternatives for many patients.

Strattera (atomoxetine) is the most commonly prescribed non-stimulant ADHD medication. Unlike stimulants, Strattera is not a controlled substance according to the DEA. This distinction is crucial because it means Strattera isn’t subject to the strict prescribing regulations that govern Schedule II stimulants. Other non-stimulant options include Qelbree (viloxazine) and medications like Intuniv (guanfacine) and Kapvay (clonidine).

The key advantage here: Because these medications aren’t controlled substances, they can be prescribed via telehealth without the federal restrictions that apply to stimulants. You don’t need a prior in-person exam under federal law, and your provider can write prescriptions for longer supplies (often 90 days instead of 30).

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Telehealth Rules: What’s Allowed Right Now

Under normal circumstances, the Ryan Haight Act requires an in-person medical evaluation before a provider can prescribe controlled substances (like ADHD stimulants) online. However, this law doesn’t apply to non-controlled medications like Strattera.

During the COVID-19 pandemic, the DEA temporarily waived in-person requirements for controlled substances, allowing telehealth providers to prescribe stimulant ADHD medications remotely. These flexibilities have been extended multiple times—most recently through December 31, 2025. A fourth extension for 2026 is anticipated, though not yet finalized.

For patients seeking non-stimulant ADHD medications, these temporary rules don’t directly impact you because there was never a federal restriction on telehealth prescribing of Strattera or similar medications. Licensed providers have always been able to evaluate you via video visit and e-prescribe non-stimulants, as long as they follow standard medical practice and are licensed in your state.

State-by-State Variations: Where You Live Matters

While federal law gives the green light for telehealth prescribing of non-stimulants, individual states have their own telehealth regulations. The good news: No state outright prohibits telehealth treatment for ADHD. However, some states have specific requirements you should know about.

States with Minimal Restrictions

California, Illinois, Pennsylvania, and Georgia place no special in-person exam requirements for telehealth prescribing of non-controlled medications. A comprehensive video evaluation with a licensed provider is sufficient to establish care and receive a prescription for Strattera.

States with Periodic In-Person Requirements

Alabama requires an in-person visit within 12 months if you’re receiving ongoing telehealth treatment for the same condition—but there’s an important exception: mental health services are exempt from this rule. Since ADHD is a psychiatric condition, many providers interpret this as allowing continuous telehealth ADHD care without mandatory in-person visits.

New Hampshire recently updated its laws (effective August 2025) to remove initial in-person requirements. Now, providers must conduct at least an annual evaluation for patients on controlled medications, but this can be done via telehealth. For non-controlled medications like Strattera, there are no additional requirements beyond standard care.

States with Controlled Substance Restrictions (That Don’t Affect Non-Stimulants)

New York reinstated an in-person prerequisite in 2025 for prescribing any controlled substance via telemedicine. This affects patients seeking stimulants but doesn’t impact Strattera prescriptions since it’s not controlled.

Florida prohibits telehealth prescribing of Schedule II stimulants except for psychiatric conditions (which ADHD qualifies as), hospitalized patients, hospice, or nursing facility residents. Again, Strattera faces no such restrictions.

Texas is very telehealth-friendly for mental health care, with no blanket in-person requirement for ADHD treatment. However, nurse practitioners and physician assistants in Texas cannot prescribe Schedule II stimulants in outpatient settings—they’re limited to hospital or hospice contexts. For non-stimulant medications or when working with a physician, Texas patients have good telehealth access.

Who Can Prescribe ADHD Medications via Telehealth?

Understanding who’s authorized to prescribe ADHD medications in your state is important when choosing a telehealth provider.

Physicians (MD/DO)

In all 50 states, licensed physicians can prescribe both stimulant and non-stimulant ADHD medications via telehealth, provided they follow DEA and state regulations. If you’re working with a psychiatrist or primary care physician through a telehealth platform, they’ll have full prescribing authority for Strattera and other ADHD medications.

Nurse Practitioners and Physician Assistants

The picture is more complex for NPs and PAs. For non-stimulant medications like Strattera, all states allow NPs and PAs to prescribe via telehealth, typically with at least a collaborative agreement with a physician.

For stimulant medications (which you might need if non-stimulants don’t work well), the rules vary significantly:

• Independent practice states (like New York, Illinois, New Hampshire, and California) allow experienced NPs to prescribe Schedule II stimulants independently after meeting certain requirements
• Collaborative practice states (like Florida and Pennsylvania) require NPs/PAs to work under physician supervision, but they can still prescribe stimulants with appropriate delegation
• Restricted states (like Georgia and outpatient Texas) severely limit or prohibit NP/PA prescribing of Schedule II medications altogether

When choosing a telehealth provider like Klarity Health, you’ll be matched with a clinician licensed in your state with appropriate prescribing authority, so you don’t need to worry about navigating these complexities yourself.

The Telehealth ADHD Evaluation Process: What to Expect

If you’re considering telehealth for ADHD treatment, understanding the evaluation process can help you prepare and set realistic expectations.

Initial Assessment

Legitimate telehealth ADHD providers conduct comprehensive evaluations that mirror in-person diagnostic processes. Expect:

• Detailed symptom questionnaires: You’ll answer questions about attention, focus, impulsivity, hyperactivity, and how symptoms affect different areas of your life (work, relationships, daily tasks)
• Childhood history: ADHD symptoms must have been present before age 12, so providers will ask about your childhood experiences, school performance, and behavioral patterns
• Video consultation: A live video visit (not just a phone call or messaging) allows the provider to observe your presentation and conduct a clinical interview
• Collateral information: Providers may request input from family members, partners, or ask to review old report cards or previous medical records to confirm symptom patterns
• Screening for other conditions: Good clinicians will screen for anxiety, depression, sleep disorders, or other conditions that can mimic or co-occur with ADHD

This isn’t a 5-minute questionnaire that automatically gets you medication. Reputable providers follow DSM-5 diagnostic criteria and take time to ensure an accurate diagnosis. The initial evaluation typically takes 45-60 minutes.

Medical History and Safety Screening

Before prescribing Strattera or any ADHD medication, your provider will review:

• Cardiovascular health: ADHD medications can affect heart rate and blood pressure, so they’ll ask about heart conditions, family history of sudden cardiac death, and current blood pressure
• Mental health history: Strattera carries an FDA warning for increased suicidal thoughts in children and adolescents, so providers carefully screen for depression or suicidal ideation
• Liver function: Since Strattera is metabolized by the liver, they’ll ask about liver disease or problems
• Other medications: To check for interactions (especially with MAOIs, which can’t be combined with Strattera)
• Substance use history: While Strattera isn’t addictive, a comprehensive substance use history helps providers choose the safest treatment approach
• Pregnancy status: If you’re pregnant or planning to become pregnant, this affects medication choices

Prescription and Follow-Up

If Strattera is deemed appropriate, your provider will:

• Send an electronic prescription to your preferred pharmacy (e-prescribing is standard practice and often legally required)
• Explain how to take the medication, typical timeline for effects (Strattera often takes 4-6 weeks to reach full effectiveness, unlike stimulants which work the same day)
• Discuss potential side effects (nausea, decreased appetite, fatigue, mood changes)
• Schedule a follow-up visit (typically within 2-4 weeks to assess response and adjust dosage if needed)

Ongoing monitoring is essential. Expect regular check-ins—monthly initially, then potentially every 3 months once stable—to track symptom improvement, side effects, and overall functioning.

Prescription Monitoring Programs: What You Should Know

Most states operate Prescription Drug Monitoring Programs (PDMPs) that track controlled substance prescriptions. While Strattera isn’t in these databases (since it’s not controlled), many states require providers to check the PDMP before prescribing any ADHD medication.

Here’s why this matters for you:

• Florida requires PDMP checks before every controlled substance prescription
• California mandates checks at least every 4 months for controlled substances
• Pennsylvania and New York require checks before the first prescription and periodically thereafter
• New Hampshire requires checking before each controlled substance prescription

Even though these requirements technically don’t apply to Strattera, expect your telehealth provider to review your medication history as part of due diligence. This isn’t about distrust—it’s about ensuring your safety and identifying potential interactions or patterns that might affect your treatment plan.

If you have a history of controlled substance prescriptions, this will come up in the discussion. Be honest about any past or current medications, including those prescribed by other doctors. This information helps your provider make the safest treatment decisions.

Insurance Coverage and Cost Considerations

Telehealth ADHD treatment has become increasingly accessible, but costs vary depending on your insurance status.

Insurance Coverage

Most major insurance plans now cover telehealth visits at the same rate as in-person visits, thanks to pandemic-era parity laws that many states have made permanent. However, coverage specifics vary:

• Evaluation visits: Typically covered like any psychiatric or primary care visit, subject to your copay or deductible
• Follow-up visits: Ongoing medication management appointments are usually covered
• Prescription coverage: Strattera is generally covered by insurance, though you may need to try it before insurance will approve stimulants (this is called ‘step therapy’)

Klarity Health accepts both insurance and cash pay, offering transparent pricing so you know costs upfront. This flexibility means you can choose whether to use insurance or pay out-of-pocket if you prefer privacy or if your insurance doesn’t cover telehealth well.

Cash Pay Options

If you don’t have insurance or prefer not to use it:

• Telehealth visits are often more affordable than traditional in-person psychiatry (which can cost $300-500 for initial evaluations)
• Cash-pay telehealth platforms typically charge $99-299 for initial consultations and $50-150 for follow-ups
• Strattera medication costs vary by pharmacy and can be pricey without insurance ($300-400/month for brand name), but generic atomoxetine is much more affordable ($30-100/month)
• Using prescription discount cards or programs can significantly reduce out-of-pocket medication costs

Red Flags and Patient Safety: How to Identify Legitimate Telehealth Providers

The ADHD telehealth space has faced scrutiny following investigations into companies like Cerebral and Done for allegedly over-prescribing stimulants without proper oversight. These high-profile cases led to DEA and DOJ investigations and temporary shutdowns of some services.

This regulatory attention has ultimately benefited patients by raising standards across the industry. Here’s what legitimate telehealth ADHD care looks like:

Signs of Quality Care

✅ Requires a comprehensive video evaluation (not just questionnaires or phone calls)
✅ Uses licensed clinicians with appropriate credentials in your state
✅ Follows DSM-5 diagnostic criteria and takes time to assess your symptoms thoroughly
✅ Discusses non-medication treatments (therapy, coaching, lifestyle changes) alongside or instead of medication
✅ Never guarantees a prescription before evaluation
✅ Schedules regular follow-ups to monitor your response and adjust treatment
✅ Coordinates with your other healthcare providers when appropriate
✅ Has clear policies about controlled substance prescribing and patient safety

Red Flags to Avoid

🚩 Claims to provide prescriptions with minimal evaluation or questioning
🚩 Guarantees ADHD medication before you’ve been assessed
🚩 Doesn’t require video visits (phone-only or messaging-only)
🚩 Doesn’t ask about your medical history, other medications, or mental health
🚩 Prescribes unusually high doses without proper titration
🚩 Doesn’t schedule follow-up appointments or check on your progress
🚩 Operates from outside the U.S. or offers to ship medications internationally
🚩 Doesn’t verify your identity or check prescription monitoring databases

Klarity Health emphasizes thorough evaluations, regular follow-ups, and evidence-based treatment approaches to ensure you receive safe, effective care that meets regulatory standards.

Why Choose Non-Stimulants? When Strattera Makes Sense

You might wonder why a provider would recommend Strattera instead of the more commonly known stimulant medications. There are several good reasons:

Medical Contraindications to Stimulants

Stimulants may not be safe if you have:

• Uncontrolled high blood pressure or heart conditions
• History of stroke or serious cardiovascular events
• Hyperthyroidism
• Glaucoma
• Severe anxiety or agitation that stimulants might worsen

Personal or Family History of Substance Use

While ADHD medications are prescribed responsibly, stimulants do have potential for misuse. If you have a personal or family history of substance use disorders, your provider might recommend starting with a non-stimulant like Strattera to eliminate any risk of dependency.

Preference for Non-Controlled Medication

Some patients prefer Strattera because:

• It’s not a controlled substance, so you can get 90-day supplies with refills (more convenient than monthly stimulant prescriptions)
• No potential for abuse or dependency
• Smoother effect throughout the day (stimulants wear off and can cause ‘crashes’)
• Can be taken once daily
• May help with co-occurring anxiety (stimulants can sometimes worsen anxiety)

Stimulants Haven’t Worked Well

If you’ve tried stimulants before and experienced intolerable side effects (severe insomnia, appetite loss, mood changes, or rebound effects), Strattera offers a completely different mechanism of action that might work better for you.

What Happens Next? Looking Ahead to 2026 and Beyond

The telehealth landscape for ADHD treatment is still evolving. Here’s what you should know about potential changes:

DEA Rules and Extensions

The current federal allowance for telehealth prescribing of controlled substances (stimulants) expires December 31, 2025. While another extension is anticipated, it’s not yet finalized. If you’re currently taking stimulants via telehealth, stay in communication with your provider about any required changes.

For non-stimulant medications like Strattera, these federal rule changes don’t directly affect you—telehealth prescribing has always been permitted and will continue regardless of what happens with controlled substance rules.

State-Level Changes

Several states are actively revising their telehealth laws:

• Some are expanding access (like New Hampshire’s 2025 law removing in-person barriers)
• Others are tightening oversight (like New York’s new in-person requirement for controlled substances)
• Many are making pandemic-era telehealth flexibilities permanent

What This Means for You

If you’re considering starting ADHD treatment via telehealth:

1. The time is now: Telehealth access to ADHD care is currently very good, especially for non-stimulants
2. Choose reputable providers: Work with established platforms that follow best practices and stay current with regulations
3. Be prepared for potential changes: If you’re on stimulants, you might eventually need an in-person visit or coordination with a local provider
4. Build a relationship: Consistent engagement with your telehealth provider creates continuity of care regardless of regulatory changes

Common Questions and Misconceptions

‘Will my local pharmacy fill a telehealth prescription?’

Yes, in almost all cases. Electronic prescriptions are standard practice and pharmacies can’t tell (and don’t need to know) whether your visit was telehealth or in-person. Strattera prescriptions face no special scrutiny since it’s not a controlled substance. Some pharmacies did scrutinize certain telehealth stimulant prescriptions during the 2023 controversies, but using an established telehealth provider and maintaining a relationship with one pharmacy minimizes any issues.

‘Is Strattera as effective as stimulants?’

Strattera works differently than stimulants and can be very effective for certain patients. While stimulants work for about 70-80% of people with ADHD, Strattera helps about 60-70%. The key difference: stimulants work quickly (within an hour) while Strattera takes 4-6 weeks to reach full effect. Many patients find Strattera provides smoother, more consistent symptom control throughout the day without the ups and downs that can come with stimulants.

‘Can telehealth doctors actually diagnose ADHD remotely?’

Yes, when done properly. Research shows that telehealth ADHD evaluations can be as accurate as in-person assessments when clinicians use structured diagnostic interviews, rating scales, and thorough clinical interviews. The key is working with providers who take the time to conduct comprehensive evaluations rather than rubber-stamping prescriptions based on a brief questionnaire.

‘What if I need to switch from Strattera to a stimulant later?’

This is very common and your telehealth provider can help with this transition. If you try Strattera for 6-8 weeks at an adequate dose and it doesn’t provide sufficient symptom relief, your provider can discuss trying a stimulant medication. Under current rules (through at least end of 2025), this can be done via telehealth. Some providers might eventually require an in-person visit depending on future regulations, but they’ll work with you to coordinate that care.

Getting Started with Telehealth ADHD Treatment

If you’re ready to explore whether telehealth ADHD treatment is right for you, here are practical next steps:

1. Research Your State’s Requirements

While most states allow telehealth prescribing of non-stimulants without special restrictions, take a few minutes to understand your state’s specific rules. The information above provides a good starting point, but your telehealth provider will ensure compliance with your state’s current laws.

2. Gather Relevant Information

Before your evaluation, collect:

• List of current medications and dosages
• Previous mental health or ADHD diagnoses and treatments
• Contact information for other healthcare providers
• Insurance information (if using insurance)
• Examples of how ADHD symptoms affect your daily life

3. Be Prepared to Discuss Your Symptoms Honestly

The quality of your evaluation depends on the information you provide. Be specific about:

• When you first noticed symptoms
• How symptoms affect work, relationships, daily tasks
• Any previous ADHD treatments and their results
• Substance use history (including alcohol, marijuana, etc.)
• Mental health concerns (anxiety, depression, mood swings)
• Family history of ADHD or other mental health conditions

4. Choose a Reputable Platform

Look for telehealth providers that:

• Employ licensed clinicians in your state
• Require video evaluations (not just questionnaires)
• Offer ongoing care and follow-up (not just one-time prescriptions)
• Accept your insurance or offer transparent cash-pay pricing
• Have clear policies about controlled substance prescribing
• Integrate or refer to therapy and other non-medication interventions

Klarity Health checks all these boxes, connecting you with experienced psychiatric providers who specialize in ADHD treatment via telehealth. With available appointment times that fit your schedule, transparent pricing whether you use insurance or pay cash, and ongoing medication management, Klarity makes getting quality ADHD care convenient without sacrificing thoroughness or safety.

5. Commit to the Treatment Process

ADHD treatment is most effective when you:

• Attend regular follow-up appointments
• Take medication as prescribed
• Communicate side effects or concerns promptly
• Consider therapy or coaching alongside medication
• Track your symptoms and functioning to help your provider assess treatment effectiveness
• Be patient—finding the right medication and dose often takes some trial and adjustment

The Bottom Line

Yes, you can get ADHD non-stimulant medications like Strattera prescribed through telehealth. These medications are not controlled substances, so federal law doesn’t restrict telehealth prescribing, and most states have no special barriers to this type of care.

The telehealth ADHD treatment landscape offers unprecedented access to care for people who struggle with busy schedules, limited local providers, or difficulty attending in-person appointments. With proper safeguards—comprehensive evaluations, ongoing monitoring, and regulatory compliance—telehealth provides safe, effective treatment that can significantly improve daily functioning and quality of life.

Whether Strattera or another non-stimulant is right for you depends on your specific symptoms, medical history, and treatment goals. A thorough evaluation with a qualified telehealth provider can help you understand your options and develop a personalized treatment plan.

If you’re ready to take the next step in addressing your ADHD symptoms, Klarity Health offers convenient access to licensed psychiatric providers who can conduct comprehensive evaluations and provide ongoing medication management from the comfort of your home. With providers available in most states, insurance accepted, and transparent pricing for cash-pay patients, getting the ADHD treatment you need has never been more accessible.

References

1. DEA ‘Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Substances’ – Federal Register, November 2024. Reported by FierceHealthcare. Available at: www.fiercehealthcare.com

2. Sheppard Mullin Healthcare Law Blog – ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions’ – National Law Review, August 15, 2025. Available at: natlawreview.com

3. Medical News Today – ‘Is Strattera a controlled substance?’ – Medically reviewed article, January 14, 2025. Available at: www.medicalnewstoday.com

4. Center for Connected Health Policy (CCHP) – State Telehealth Laws: Online Prescribing – Accessed November 2025. Available at: www.cchpca.org

5. SingleAimHealth – ‘Can an NP Prescribe Schedule 2 in Texas?’ – Updated December 9, 2025. Available at: www.singleaimhealth.com

Source:

• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20Drug%20Enforcement%20Administration%20,Federal%20Register%20on%20Friday%20night
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=visit,examination%20through%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20%E2%80%9CThird%20Temporary%20Extension%20of,14
• https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance#:~:text=Strattera%20,such%20as%20mental%20health%20issues
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20,False%20Hope
• https://www.techtarget.com/virtualhealthcare/news/366616019/Telehealth-prescribing-flexibility-extended-through-2025#:~:text=Image%20filo%2FDigitalVision%20Vectors%20via%20G,The
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Extend%20natlawreview,before%20issuing%20a%20dangerous%20drug
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=,specifically%20for%20chronic%20pain%20treatment